Stoke Therapeutics Inc.

NASDAQ: STOK · Real-Time Price · USD
10.91
1.00 (10.09%)
At close: Jun 03, 2025, 3:59 PM
11.20
2.65%
After-hours: Jun 03, 2025, 06:09 PM EDT

Stoke Therapeutics Revenue

Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending March 31, 2025, Stoke Therapeutics generated $158.57M in revenue.
Revenue (ttm)
$36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
$285.59K
Employees
128
Market Cap
595.93M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.